title: Next-Generation Antibody-Drug Conjugates (ADCs) for Cancer Therapy.
authors.affiliation: Vice President, Antibody Discovery & Development, Cellerant Therapeutics, Inc.
authors.forename: Jagath Reddy
authors.initials: JR
authors.lastname: Junutula
authors.affiliation: CSO and Vice President, Targeted Therapeutics Discovery, Oncology Research Unit, Pfizer Worldwide Research and Development.
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Gerber